Chris Swain - Equilibar

Chris Swain

Data Analyst

Production Liaison

Chris Swain, Equilibar’s Data Analyst, uses his strong technical skills and his understanding of Equilibar’s production process to make sure the information channels are clear and effective.

“At Equilibar, the day tends to fly by when we experience a bit of a rush of orders,” Chris said. “Having a little extra responsibility on my plate helps me to maintain focus and constantly work towards ensuring all tasks are accomplished on time.”

Chris has a Bachelor of Science Degree in Aeronautical Science. He had a successful career building and maintaining websites in the early days of the internet.

“My main objective in coming back to work was to find a fun, friendly, relaxed group of people that enjoy working together and enjoy the work they are trying to accomplish,” Chris said. “Equilibar is a perfect fit for me in each of these aspects.”

Like many of our team members, Chris is an avid biker. “In the past couple of years I’ve discovered the incredible joy of jumping on a bike and flowing over the rolling hills of Western North Carolina,” he said. “The scenery is always beautiful, the exercise is beneficial, and my mental state after a ride is always a TEN!”

Chris has traveled to many countries around the world and has visited Equilibar colleagues in Korea. “International travel is a new passion of mine, discovered late in life,” he said. “There are so many cultures to explore, so many spots of natural beauty to see, so many new and yummy foods to ingest! I’ll be traveling as much as possible until the end of my life.”

Equilibar News
cover of PI magazine

Process Instrumentation cover story: Ryan Heffner discusses pharmaceutical fluid control

The November issue of Process Instrumentation magazine features a cover article by Ryan Heffner, single use technology manager for Equilibar, that provides a comprehensive overview of fluid control options for the fast-changing pharmaceutical industry. Researchers responding to the COVID epidemic dramatically accelerated the rate of change in the pharmaceutical industry as they developed vaccines and Read More

Read More